201 related articles for article (PubMed ID: 10690173)
1. Papillary hidradenoma: immunohistochemical analysis of steroid receptor profile with a focus on apocrine differentiation.
Offidani A; Campanati A
J Clin Pathol; 1999 Nov; 52(11):829-32. PubMed ID: 10690173
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors.
Selim AG; Wells CA
J Clin Pathol; 1999 Nov; 52(11):838-41. PubMed ID: 10690175
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
4. Intraductal carcinoma of mammary-type apocrine epithelium arising within a papillary hydradenoma of the vulva. Report of a case and review of the literature.
Pelosi G; Martignoni G; Bonetti F
Arch Pathol Lab Med; 1991 Dec; 115(12):1249-54. PubMed ID: 1662944
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina.
Hodgins MB; Spike RC; Mackie RM; MacLean AB
Br J Obstet Gynaecol; 1998 Feb; 105(2):216-22. PubMed ID: 9501790
[TBL] [Abstract][Full Text] [Related]
6. [Anatomoclinical and immunohistochemical study of hidradenoma papilliferum, a tumor deriving from anogenital mammary-like glands].
Blind A; Weingertner N; Cribier B
Ann Dermatol Venereol; 2019 Sep; 146(8-9):528-536. PubMed ID: 31285043
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and Molecular Characteristics of Anogenital Papillary Hidradenomas.
Karpathiou G; Sim A; Picot T; Mekhzoumi K; Chauleur C; Péoc'h M
Am J Dermatopathol; 2024 Feb; 46(2):79-82. PubMed ID: 38055985
[TBL] [Abstract][Full Text] [Related]
8. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature.
Parks A; Branch KD; Metcalf J; Underwood P; Young J
Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses.
van Doorn HC; Burger CW; van der Valk P; Bonfrèr HM
J Clin Pathol; 2000 Mar; 53(3):201-5. PubMed ID: 10823139
[TBL] [Abstract][Full Text] [Related]
10. Giant apocrine hidradenoma of the breast.
Knoedler D; Susnik B; Gonyo MB; Osipov V
Breast J; 2007; 13(1):91-3. PubMed ID: 17214802
[TBL] [Abstract][Full Text] [Related]
11. Papillary hidradenoma of the eyelid margin: clinical and immunohistochemical observations further supporting an apocrine rather than an eccrine origin.
Jakobiec FA; Rai R; Lefebvre DR
Surv Ophthalmol; 2014; 59(5):540-7. PubMed ID: 24661803
[TBL] [Abstract][Full Text] [Related]
12. Hidradenoma papilliferum of the vulva in association with an anogenital mammary-like gland.
Kurashige Y; Kishida K; Kurashige K; Minemura T; Nagatani T
J Dermatol; 2014 May; 41(5):411-3. PubMed ID: 24617304
[TBL] [Abstract][Full Text] [Related]
13. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
14. Vulvar hidradenoma papilliferum (HP) is located on the sites of mammary-like anogenital glands (MLAGs): Analysis of the photographs of 52 tumors.
El-Khoury J; Renald MH; Plantier F; Avril MF; Moyal-Barracco M
J Am Acad Dermatol; 2016 Aug; 75(2):380-4. PubMed ID: 26944596
[TBL] [Abstract][Full Text] [Related]
15. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands.
Nishie W; Sawamura D; Mayuzumi M; Takahashi S; Shimizu H
J Cutan Pathol; 2004 Sep; 31(8):561-4. PubMed ID: 15268713
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study.
Cardillo MR; Petrangeli E; Aliotta N; Salvatori L; Ravenna L; Chang C; Castagna G
J Exp Clin Cancer Res; 1998 Jun; 17(2):231-7. PubMed ID: 9700586
[TBL] [Abstract][Full Text] [Related]
17. Expression of growth hormone-releasing hormone receptors in apocrine adnexal tumours and apocrine glands of the skin.
Kővári B; Kocsis L; Varga E; Cserni G
Pol J Pathol; 2018; 69(1):48-52. PubMed ID: 29895126
[TBL] [Abstract][Full Text] [Related]
18. Anogenital "sweat" glands. Histology and pathology of a gland that may mimic mammary glands.
van der Putte SC
Am J Dermatopathol; 1991 Dec; 13(6):557-67. PubMed ID: 1666822
[TBL] [Abstract][Full Text] [Related]
19. Atypical and malignant hidradenomas: a histological and immunohistochemical study.
Nazarian RM; Kapur P; Rakheja D; Piris A; Duncan LM; Mihm MC; Hoang MP
Mod Pathol; 2009 Apr; 22(4):600-10. PubMed ID: 19252473
[TBL] [Abstract][Full Text] [Related]
20. Mapping of androgen, estrogen and progesterone receptors in the anal continence organ.
Oettling G; Franz HB
Eur J Obstet Gynecol Reprod Biol; 1998 Apr; 77(2):211-6. PubMed ID: 9578281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
